Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced the launch of two new ...

First-ever FDA approved PROTAC supports the further development and potential of Arvinas’ pipeline –– Announced FDA Approval of VEPPANU™ ...

What are the first steps that chart the path for a cell to become a blood cell, neuron cell, or pigment cell? Scientists have developed increasingly powerful tools to track those changes, but one ...

Short QT syndrome is a genetic disease that leads to sudden cardiac death at a young age. Mutations in the SLC4A3 gene, which ...

Short QT syndrome is a genetic disease that leads to sudden cardiac death at a young age. Mutations in the SLC4A3 gene, which ...

Researchers at the University of Toronto's Institute of Biomedical Engineering have developed a new method to mature ...

Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue ...

Scientists discover human heart can regrow muscle cells after heart attack, opening path to regenerative therapies.

For the first time, scientists have shown that heart muscle cells can regrow after a heart attack in humans, a process that ...

An international research team with the participation of researchers from the University Medical Center Göttingen (UMG), Germany, has developed a mouse model that offers new insights into the ...

Although cell therapy has emerged as a promising approach to promote neovascularization, its effects are mostly limited to capillaries. To generate larger or more stable vessels, layering of mural ...